Ligands for the cysteine-nch (CR) domain of the mannose receptor (MR) were detected by incubating murine tissues with a chimeric protein containing CR fused to the Fc region of human IgG1 (CR-Fc). In naive mice, CR-Fc bound to sialoadhesin +, F4/80 l°w/ , macrosialin + macrophages (Mo) in spleen marginal zone (metallophilic Mo) and lymph node subcapsular sinus. Labeling was also observed in B cell areas of splenic white pulp. Western blotting analysis of spleen and lymph nodes lysates revealed a restricted number of molecules that interacted specifically with CR-Fc. In immunized mice, labeling was upregulated on germinal centers in splenic white pulp and follicular areas of lymph nodes. Kinetic analysis of the pattern of CR-Fc labeling in lymph nodes during a secondary immune response to ovalbumin showed that CR ligand expression migrated towards B cell areas, associated with cells displaying distincnve dendritic morphology, and accumulated in developing germinal centers. These studies suggest that MR + cells or MR-carbohydrate-containing antigen complexes could be directed towards areas where humoral immune responses take place, through the interaction of the MR CR domain with molecules expressed in specialized macrophage populations and antigen transporting cells,
T
he mannose receptor (MR) l is a 175-kD type I transmembrane protein expressed in macrophages (Mo), dendritic cells (1) , and hepatic endothelial cells, that mediates phagocytosis of saccharide-coated particles as well as pinocytosis of soluble glycoconjugates (2) . The expression of the MR is highly regulated; it appears only during terminal differentiation of Mo and is modulated by steroids and cytokines. In biogel polyacrylamide bead-elicited peritoneal Mo MR mRNA and endocytic activity are downregulated by IFN-~/and upregulated by IL-4 and IL-13 (3--5) . Three types of domain have been described in the extracellular region of this molecule: a cysteine-rlch (CR) domain that contains a module that resembles a domain of the B chain of the plant lectin Ricin (6), a domain with fibronectin type II repeats (FNII), and eight C-type carbohydrate recognition domains (CRD) that mediate ligand binding 1Abbreviations used in this paper: CR, cysteine-nch; CRD, carbohydrate recogmtlon domain; CR1, complement receptor 1; CR-Fc, cysteme nch-Fc chimera; FNII, fibronectm type II; FDC, folhcular dendrinc cell; Mo, macrophage; MR, mannose receptor; MZ, marginal zone; PNA, peanut agglutinin; Sn, slaloadhesm. (7) (8) (9) (10) . Of these, only CRDs 4-8 show affinity for carbohydrate and only CRD4 exhibits multiple specificities (9, 10) . This structure IS conserved among the members of the "MR family" that includes the dendritic cell and thymic epithelium marker DEC-205 (11) , which contains 10 CRDs, and phospholipase A2 receptors (12, 13) .
No function has been found for the CR and FNII domains of the MR, but amino acid sequence comparison between the human and murine forms of the receptor shows 86% identity in the case of the CR and 93% in the case of the FNII domain (4) . Such a degree of conservation is suggestive of an important function for these regions. In this study we have used chimeric proteins containing both CR and FNII domains or only the CR domain of the murine MR fused to the Fc region of human IgG1 (14) , to detect ligands in mouse tissue. In non-immunized mice, both proteins bound equally to the marginal zone of spleen, the subcapsular sinus of lymph node and B cell areas of splenic white pulp. Phenotypac characterizanon of the cells that express the ligand(s) will be presented. Several molecules that interact specifically with CR-Fc in Western blot analysis, have been detected in spleen and lymph node protein lysates.
After antigen stimulation ligand activity was also detected in germinal centers m spleen and lymph nodes. Kinetic studies showed that cells with ligand activity appeared to migrate towards B cell areas and accumulate in developing germinal centers of draining lymph nodes. These studies indicate that MR (i.e., MR + cells) could be directed, through its interaction with specific molecules expressed in spleen and lymph nodes via domain(s) not involved in carbohydrate recognition, to areas where attinity maturation of B cell responses occur (i.e., the germinal center).
Materials and Methods
Animals. C57B1/6, Balb/c and op/op mice were bred at the Dunn School of Pathology and used at 7-8 wk of age. Balb/c SCID mice were obtained from Harlan (Bicester, UK) and tissues from rag/rag rnlce were a kind gift from Dr. D. Kioussls (NIMR, Mill Hill, London).
Antibodies. The following rat mAb were prepared in our laboratory: Ser-4 and 3D6, used together to detect sialoadhesin (Sn) (15, 16) , F4/80, specific for a Mo plasma membrane differentiation antigen (17) , and FAll that recognizes rnacrosialin (18) . Other antibodies used were: FDC-M1 (19) , M5/114 (specific for MHCII), obtained from the Arnencan Tissue Type Collection (Rockville, MD), 8C12 (specific for complement receptor 1, CR1) (20) , and B220, obtained from PharMingen (San Diego, CA). Purified human IgG1 was obtained from Sigma (Poole, Dorset, UK).
Immunization. Mice were primed subcutaneously in the back of the neck with OVA precipitated in alum (101) ~g) and 2 wk later challenged intraperitoneally (100 Ixg) or subcutaneously (50 lxg per limb) with the same antigen, as described elsewhere (21) .
Fc Chimeras. Primers MP, I:5'GGGATATCGACCTTGGAC-TGAGCAAAGGGGCAACCTGG3' and MR.5:5'GGGAAT-TCACTTACCTGTCTCGCTTCCCTCAAAGTGCAATGG-ACAAAA3' were used to amplify the leader sequence, CR domain and FNII domain of the MR by RT-PCR using as template cDNA from biogel-eliclted peritoneal Mo that had been reduced to express high levels of MR by IL-4 treatment (5 ng/ml), as described (3, 5) . To amplify only the leader sequence and CR domarn a new primer was designed: MR11:5'GGGAATTC-ACTTACCTGTGGAGTACATGGCTTCATATCCTCTCGA-GCA3'. MR1 contained an EcoRV site (underlined) and MR5 and MR11 contained the splicing signal ACTTACCTGT and an Ec___RoRI site (underlined). PCR products were digested with EcoRV and EcoP, J, cloned into the piG expression vector (14) , and sequenced. The chimeric proteins, CR and FNII domains, or CR domain of the MR alone, fused to the Fc portion of human IgG1 (CR-FNII-Fc and CR-Fc) (see Fig. 1 A) , were purified from supernatants oftransfected Cos 7 cells by protein A chromatography (Pharrnacla, Uppsala, Sweden). CR-FNII-Fc formed some aggregates after SDS-PAGE analysis, but a major band was observed of 65 kD under reducing conditions and 130-140 kD under non-reducing conditions. CR-Fc migrated as a single species in reducing and non-reducing SDS-PAGE, with a molecular mass of 50 and 100 kD, respectively (see Fig. 1 Immunohistochemistry. Organs were collected and frozen in O.C.T. compound (BDH-Merck, Poole, Dorset, UK) cooled in isopentane over dry ice. Frozen sections were cut at 5 Ixm, airdried for 1 h, and stored at -20°C. Before staining, sections were thawed at room temperature for 1 h and fixed for 10 man in 2% paraformaldehyde in Hepes-buffered isotonic saline at 4°C or in acetone at room temperature. In some cases, animals were perfusion-tLxed with 2% periodate-lysine-paraformaldehyde. After postfixing in the same solution for 4 h, tissues were impregnated with 20% (wt/vol) sucrose in 0.1 M phosphate buffer overrnght, before freezing and sectioning.
Fixed sections were washed in PBS containrng 0.1% (vol/vol) Tnton X-100 and endogenous peroxidase activity blocked by incubating sections with 10 -2 M glucose, 10 -3 M NAN3, 40 U glucose oxidase (Sigma) in 100 ml phosphate buffer for 15 min at 37°C. When chimeric proteins were used, sections were incubated with 5% (vol/vol) normal goat or mouse serum (blocking buffer) for 30 rain and with hlgG1 or Snl-Fc, MAG1-5-Fc, CR-FNI1-Fc, or CR-Fc proteins diluted at 10 Ixg/ml rn blocking buffer for 60 min. Binding was detected by incubation ofsecnons with biotinylated goat anti-human IgG (Vector, Peterborough, UK) or biotinylated mouse anti-human F(ab')2 (Jackson ImmunoResearch Labs., West Grove, PA) diluted rn blocking buffer, followed by avidin-biotin-peroxidase complex (ABC elite; Vector) and 0.5 mg/rnl diarnrnobenzldlne (Polysciences Inc., Northampton, UK) with 0.024% H20 2 in 10 rnM Imldazole in PBS, pH 7.4. In the case of rat mAb, the blocking buffer was 5% (vol/vol) normal rabbit or mouse serum and a biotrnylated rabbit ann-rat IgG (Vector) or mouse anti-rat IgG (Fab')2 (Jackson) was used to detect binding. Sections were counterstained with crystal violet or methyl green. In the case of double immunocytochemlstry with CR-Fc and rat Ab, the first starnlng step with the above protocol was followed by blocking with avidin-biotrn (Vector). For the second step, avidin-biotrn-alkahne phosphatase complex (ABC-AP) and Vector blue detecnon system (Vector) were used.
Cytospin preparanons were air dried and kept at -20°C. Before use, cells were fixed, permeabilized, and endogenous peroxidase quenched as above. In this case blocking was performed ,n 5% (vol/vol) normal mouse serum in PBS. Cells were incubated with MAG1-5-Fc or CR-Fc (10 Ixg/ml) diluted in 5% normal mouse serum for 1 h, and CR-Fc binding detected as above. Cells were counterstained with hematoxylin. For double lrnrnunofluorescence on isolated cell preparations, fixed and perrneabihzed cells were incubated in 5% (vol/vol) normal mouse serum for 30 rmn, followed by CR-Fc (10 btg/ml) and rat mAb diluted In 5% (vol/vol) normal mouse serum for 60 ram. Binding was detected by incubation w~th biotmylated mouse anti-human F(ab')2 and FITC-mouse anti-rat IgG (Fab')_~ (Jackson) for 30 turn and Texas red-avldin (Vector) for 30 min.
Enrichment ofCR-Fc + Cells. Spleens and peripheral lymph nodes from normal mace were digested using 2.5% (wt/vol) collagenase D and 0.1% DNase (Boehringer Mannhmm, Lewes, East Sussex, UK) in Iscove's modified Dulbecco's medmm (IMDM). After digestion, erythrocytes in spleen were lysed following Gey's procedure (24) . Cell suspensmns were washed and loaded on a performed continuous percoll gradient (Pharmacia) (1-2 × 108 cells/ gradient) and centrifuged at 400 g for 30 rain. The two major bands (low and high density cells) were collected, washed m IMDM and prepared for analysis by irnmunocytochemlstry. 105 cells were placed on poly L-lysine treated slides by centrifugatmn at 400 rpm for 5 min using a cytocentrifuge (Life Sciences International, Basingstoke, UK). Western Blotting Using CR-Fc. Mouse tissue lysates prepared in 2% (vol/vol) Triton X-100 m 10 mM tns-HC1, 150 mM NaC1, 2 mM EDTA, 10 mM NAN3, 5 mM iodoacetamlde, 2 mM PMSF, 1 ~g/ml pepstatin, and 1 p.M leupeptin were boiled in sample buffer (10 mM tns-HC1, pH 6.8, 2% SDS, 20% glycerol, 0.001% (wt/vol) bromophenol blue) and resolved on a 6% SDS-PAGE. After electrophoresls, proteins were transferred to nitrocellulose (C-hybond; Amersham, Arnersham, UK) and the filters blocked in 5% (wt/vol) nonfat milk in PBS, 0.1% Tween 20 for 1 h and probed with CR-Fc (10 btg/ml in blocking buffer) for 1 h. Binding was detected by incubation with peroxidase-coupled anti-human IgG (Sigma) diluted 1:5,000 in blocking buffer and chemiluminescence kit (ECL; Amersham).
R e s u l t s

Localization of Ligands for the CR Domain of the MR in Mouse Tissue Sections by Immunocytochemistry in Normal Mice.
The CP, and FNII domains o f the murine M R or the CP,. domain alone were fused to the Fc portion of human IgG1 (CP,-FNII-Fc and CR-Fc) ( Fig. 1 ) and used to label various mouse tissues using human IgG1 or other chimeric proteins (MAG1-5-Fc and Snl-Fc) as negative controls. Identical labeling patterns were observed in spleen (Fig. 2 , compare row C with D) and lymph nodes (data not shown) with both proteins indicating that the binding of CP,.-FNII-Fc was due to its CP, domain. In naive mice (Fig. 2, column 1) , these chimeric proteins bound to cells located in the marginal zone (MZ) o f the spleen (Fig. 2, 1C and 1D) and in the subcapsular region of lymph nodes (LN) (see Fig. 4 B) . There was no labeling in spleen (Fig. 2 , rows A and B) or LN (see Fig. 4 A) with other chimeric proteins or human IgG1 and C R -F c binding was not influenced by the presence of the Fc receptor blocking reagent 2.4G2 (PharMingen; data not shown). N o specific binding was observed in lung, liver, muscle, skin (epidermis or dermis), brain or bone marrow (data not shown). In spleen, C R -F N I I -F c and C R -F c labeling included metallophilic M Z Mo which express high levels ofsialoadhesin (Sn) (Fig. 2,   compare 1C, ID, 1G ). Double immunolabefing using CR-Fc and 3 D 6 / S E R -4 (specific for Sn) confirmed this observation (Fig. 3 C) . C R ligand activity was absent in Sn + Mo in the outer M Z and in the red pulp (Fig. 3, compare A with  B) . Double immunolabeling using C R -F c and F4/80 antibody, specific for red pulp Mo in the spleen, established that neither probe bound to cells in the outer M Z (Fig. 3  D) . CR-Fc+Sn + metallophilic Mo also expressed the pan-Mo and dendritic cell marker macrosiahn which in addition was found in red pulp, white pulp and outer M Z Mo (Fig.  3 E) . Weak C R -F c labeling was detected in B cell areas in the white pulp o f normal spleen that are strongly positive for complement receptor 1 (CR.1) (Fig. 2, 1E ) and weakly positive for the follicular dendritic cell marker M1 (FDC-M1, Fig. 2, IF) . N o labeling in T cell areas was found.
In unstimulated peripheral lymph nodes, CP,.-Fc binding was detected in a subpopulation of Sn + macrosialin + M o located in the subcapsular sinus (Fig. 4, compare B, C, D) . Again no co-localization o f CP,-Fc ligand(s) (Fig. 4 B) and F4/80 (Fig. 4 F) was observed.
The characterization o f M Z C R -F c + cells and subcapsular sinus CR.-Fc + cells as Sn + macrosialin + Mo was confirmed by labeling spleens from op/op mice which lack M Z and M Z metallophilic Mo, M-CSF-dependent Mo populations (25) (Fig. 2, column 3 ). In these animals no CR.-Fc binding to the M Z of spleen (Fig. 2, 3C and 3D) and no 3 D 6 / S E R -4 labeling (Fig. 2, 3G) were detected.
Similar results were obtained in the case of the subcapsular sinus of LN (data not shown). Work with op/op mice also showed that the labeling observed in follicular areas was independent of the presence of MZ, because C R -F N I I -F c and CR.-Fc still bound to B cell areas (CRA +, FDC-M1 +) (Fig. 2, compare 3C, 3D, 3E, 3F ).
C R -F c binding was Ca 2+ and ~+ " -Mg--independent, because no changes in the labeling pattern were noticed in the presence of E D T A (data not shown). CP,. binding activity was also T and B cell-independent; C R -F c bound to similar areas in spleen and lymph nodes from SC|D and r a g -/ -mice though the abnormal morphology of the M Z in spleen makes any precise comparison difficult (data not shown).
Ex Vivo Phenotypic Characterization of CR-Fc + Cells. The procedure used to enrich CP,-Fc + cells was originally developed to isolate follicular dendritic cells (FDCs) from immune lymphoid tissue (26) . In the present case we used tissue from naive animals and compared the cells obtained from collagenase digested spleen and lymph nodes. Cell suspensions were fractionated by percoll gradient and high and low density fractions collected as described in Materials and Methods. Immunocytochemical analysis of cytospin preparations from both cell populations was performed with CR-Fc to estimate enrichment of CR-Fc + cells. These cells were found in the low density fraction where they represented less than 0.1% of total cells. No significant number of CRFc + cells was found in the high density fraction. No FDC-M1 + cells were obtained from non-immunized mice under these conditions. CR-Fc + cells appeared large with cytoplasmic processes and were isolated or part of cellular clusters. They contained a granular cytoplasm and CR-Fc staining was localized strongly but not exclusively to the plasma membrane (Fig. 5) . Double immunofluorescence showed that most CR-Fc + cells isolated from naive animals are macrosialin +, Sn +, MHCII l°w/-, F4/8(~ °w/-, CR1 negative, and B220 negative (data not shown). Therefore the populations of CR binding cells isolated following this method are likely to represent mainly MZ metallophilic Mo from spleen and subcapsular sinus Mo from LN.
Detection of Molecules with CR Binding Activity.
Blotting of normal tissue lysates with CR-Fc allowed the characterization of molecules that interact with CR. As shown in Fig. 6 , several proteins ranging in size from 80 to more than 300 kD were specifically recognized by CR-Fc in spleen and LN lysates. No proteins were detected by CR-Fc in liver lysates (which totally lack reactivity with CR-Fc by immunocytochemistry) or by other control chimeric proteins in any of the lysates tested.
This complex pattern was highly reproducible, was obtained with CR-FNII-Fc and CR-Fc (data not shown) and was independent of the detergent used to prepare the lysate ([3-octylglucoside, CHAPS, or NP-40). In an attempt to increase sensitivity, lysates were immunoprecipitated with CR-Fc, electrophoresed under non-reducing conditions, blotted, and incubated with CR-Fc conjugated to digoxigenin followed by an anti-digoxigenin antibody. No differences were observed (data not shown). (Fig. 2, c Fig. 7 , changes in CR-Fc labehng were observed at different times during a secondary response to ovalbumin. Background labeling using a control chimeric protein was minimal (Fig. 7 A) . Before injection (Fig. 7 /3 , Day 0) the CR-Fc protein bound to cells restricted to the subcapsnlar sinus and trabeculae entering the tissue. Within 24 h of antigenic challenge (Fig. 7 C) , labeling appeared to move into the first layers of lymphocytes. C R binding activity continued to move deeper by 48 h (Fig. 7 D) , with CR-Fc + cells displaying distinctive dendritic processes that could be especially seen by day 3 (Fig. 7 E) . At this point the label appeared to have begun to accumulate in the B cell follicles as well as to move towards the paracortex. Interestingly, as seen by day 4 (Fig. 7 F) , cells generating the FDC network (arrows) in the developing germinal center (PNA labeling; serial section, Fig. 7 K) also bound the CR-Fc protein; labeling diminished as the other positive cells approached the T cell zone. This disappearance may indicate that the ligand was internalized and degraded. From day 5 (Fig. 7 G) onward (Fig. 7, H, I , and J, respectively, days 6, 10, and 12), labeling became more restricted to the subcapsular sinus and the FDC network (Fig. 7, G-J, arrows) within germinal centers (PNA labeling serial sections, Fig. 8, L-O, days 5, 6 , 10, and 12, respectively). By day 12, the distribution resembled that of day 0 with the additional labeling of the antigen-retaining FDCs. These results show that during an immune response C RFc binding activity moved towards the follicles and became concentrated in the germinal centers.
Localization of Ligands for CR-Fc in Immunized Mice. After i n d u c t i o n o f g e r m i n a l center f o r m a t i o n in n o r m a l m o u s e spleen b y i m m u n i z a t i o n w i t h O V A
Discussion
M R plays an important role in endocytosis and phagocytosis of sugar bearing molecules and particles. As such, the focus of studies to date has been on the domains involved in carbohydrate recognition (CRDs), defining receptor specificity, binding properties (9, 10) , and its intracellular trafficking (2) . The most conserved regions between the human and routine forms of the M R are the C R and FNII domains which are located at the amino terminus of the molecule (4). This degree of conservation as well as their localization at the same region in other members of the M R superfamily, i.e., DEC205 and phospholipase A2 receptors, suggest an important role for these domains that might be common to all these proteins. Our results show that there is/are ligand(s) for the C R domain of the murine form of the M R in mouse spleen and lymph nodes. Our strategy involved the use of Fc chimeric proteins containing either both C R and FNII domains of the MR., or the C R domain alone (Fig. 1 A) , to search for hgands in murine tissues. The observation that CR-FNII-Fc and CR-Fc showed identical labeling patterns (Fig. 2 , compare row C with D) suggested that their binding was due to the presence of the C R domain alone and that this region has a similar conformation in both proteins. Areas where most CR-Fc + cells are located in naive animals are thought to be involved in cell and antigen trafficking. Previous studies have described binding of lymphocytes (27) (28) (29) (30) , macrophages (31), dendritic cells (32) , as well as of exogenous antigens (33, 34) to splenic MZ (35) or to the subcapsular sinus of LN (30, 31) .
Additional weaker staining with CR-Fc was observed in follicular areas (CR1 +, Fig. 2 1E, Fig. 3 F) in normal splenic white pulp, which we have not yet assigned to a specific cell type; no F A l l -, Sn-cells that bound CR-Fc were found after spleen or LN digestion suggesting that CR-Fc + follicular cells were not isolated by this procedure. Specific follicular labeling correlated with the degree of antigen stimulation, was more commonly found in spleen and mesenteric lymph nodes than in the peripheral lymph nodes of naive animals and varied among mice independent of the constant presence of Clq,-Fc binding activity in the subcapsular sinus of LN and MZ of spleen. In particular, labeling of op/op mouse spleens (Fig. 2, column 3) showed that this follicular label was present in the absence of MZ Mo. After immunization with ovalbumin, follicular labeling increased markedly in spleen and LN; it was located in germinal centers and co-localized with CR.I, the FDC marker FDC-M1 (36) (Fig. 2 , compare 2C and 2D with 2E and 2F) and PNA labeling (data not shown).
To identify the origin of the follicular labeling observed after antigen stimulation, peripheral lymph nodes collected at different times during a secondary immune response were labeled with CR.-Fc. The results from this experiment, shown in Fig. 7 , suggested that the origin of the follicular staining could be the concentration of CR-binding cells in this area. Early after immunization CR` binding activity, associated with cells that were dendritic in appearance, seemed to migrate towards the B and T cell areas and then became localized in germinal centers. This could be due to the movement of CR`-Fc + cells or the transfer of CR. ligand(s) from one cell type to another. According to our results, the time course of Ctk-Fc + cells moving into these regions paralleled the kinetics for the movement of antigen into germinal centers reported by Szakal et al. (37) , and these cells may correspond to the antigen transporting cells characterized by these authors.
Five species of Ctk binding proteins have been detected in protein lysates from spleen and lymph nodes (Fig. 6) which raised concern about the specificity of CR.-Fc in this assay. Because the patterns obtained were highly reproducible and specific for the organs where CR binding was detected, and because no other chimeric proteins recognized any of these species, we consider these proteins to be putative ligands for the CR domain of the MR.. Their nature is undefined; they could represent multimers, different spliced or cleaved forms of the same molecule or distinct molecules that share the same CI~ binding motif. Nor is it known whether particular cells that bind CR`-Fc by immunocytochemistry express all of these molecular species detected in tissue lysates. Experiments are in progress to purify the putative ligand(s) from spleen lysates, and to characterize the nature of their interaction with the CR domain of the MR. At the same time comparison between the patterns obtained with tissues from naive and immunized mice is under way to characterize molecules that could be upregulated aRer antigen stimulation.
The data presented in this study indicate that MR is able to interact through its CR` domain with hgands expressed by cells located in areas involved in cell and antigen transport and regulated by antigen stimulation. The binding of the CR domain to ligands could mediate the trapping of MR + cells (Mo and dendritic cells) and their delivery to follicular areas. The relevance of the interaction between MZ metallophilic and subcapsular sinus Mo with MR + cells through the MR., a receptor that mediates phagocytosis and endocytosis, is not clear. A possibility we considered is the existence of a soluble form of the MR, as has been described for the human 180-kD receptor for secretory phospholipases A 2 (12) , that could be trapped by cells bearing CR. ligands and transported to follicular areas. Such a form has recently been found in supernatants from biogelelicited peritoneal Mo (Martinez-Pomares, L., J. Mahoney, and S. Gordon, manuscript in preparation), but no in vivo data are yet available. We postulate that carbohydrates or carbohydrate-bearing molecules could be directed, through their binding to the CRDs of the mannose receptor and subsequent interaction of the complex with the CR-ligand(s), to B cell areas in a way similar to complement and antibody-bound antigens. This would be an alternative mechanism for the transport of native antigens to sites where high affinity B cells responses are occurring. 
